Drug Side Effects
Search
HER2 POSITIVE GASTRIC CANCER
HER2 POSITIVE GASTRIC CANCER
was reported 32 times
HER2 POSITIVE GASTRIC CANCER is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Bispecific HER2-directed Antibody [EPC]
1
0.0122
1
Substance P/Neurokinin-1 Receptor Antagonist [EPC]
6
0.0007
2
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
2
0.0003
3
HER2/neu Receptor Antagonist [EPC]
11
0.0001
4
Bile Acid [EPC]
2
0.0001
5
Platinum-based Drug [EPC]
19
0.0001
6
Nucleoside Metabolic Inhibitor [EPC]
18
0.0001
7
Orexin Receptor Antagonist [EPC]
1
0.0001
8
Microtubule Inhibitor [EPC]
3
0.0000
9
Serotonin-3 Receptor Antagonist [EPC]
2
0.0000
10
Dihydropyridine Calcium Channel Blocker [EPC]
4
0.0000
11
Nucleoside Analog Antiviral [EPC]
1
0.0000
12
P2Y12 Platelet Inhibitor [EPC]
1
0.0000
13
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
14
RANK Ligand Inhibitor [EPC]
1
0.0000
15
Atypical Antipsychotic [EPC]
2
0.0000
16
Kinase Inhibitor [EPC]
2
0.0000
17
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
18
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
19
Loop Diuretic [EPC]
1
0.0000
20
Proton Pump Inhibitor [EPC]
1
0.0000
21
Benzodiazepine [EPC]
1
0.0000
22
Corticosteroid [EPC]
1
0.0000